Pladis UK&I products met cinema legends at the BAFTAs in London. Alan Cumming distributed traditional British snacks to famous actors, creating a warm atmosphere.
Author: Aino Lehtinen
Aino Lehtinen
Aino Lehtinen is a Finnish journalist and editor originally from Helsinki, Finland. She studied Media and Communication Studies at the University of Tampere, where she developed a strong interest in investigative storytelling and cross-border journalism. After several years working with leading Finnish publications, she relocated to Berlin, Germany, where she currently lives and works as a freelance editor. Lehtinen focuses on issues such as digital privacy, press freedom, and the intersection of media and politics in Europe. Fluent in Finnish, English, and German, she often collaborates with international media outlets on transnational reporting projects.
Former Google executive Matt Brittin is the primary choice to lead the BBC. Several major media candidates have recently withdrawn from this selection process.
Ridley Scott’s 2012 sci-fi film Prometheus, which earned $403.4 million worldwide, has climbed back into Netflix’s global movie charts more than a decade later.
The integration of artificial intelligence in healthcare is transforming patient care and operational efficiency, marking a significant shift in the industry.
Frederiksberg-based Hemi Health raises €4 million in Seed funding to enhance migraine and concussion treatment, with plans to expand into the Netherlands.
Umlaut.bio, a biotech firm specializing in oncology and immunology, has successfully raised approximately €3 million in pre-seed funding, supported by BaseLaunch, to develop novel tRNA-modifying therapeutics.
Activist investor Starboard Value strongly pressures the Tripadvisor board for an immediate company sale, citing poor financial outcomes and dropping stock values.
Axmed secures funding to enhance access to quality medicines in low- and middle-income countries, building on previous support from the Gates Foundation.
Rome-based VoiceMed has successfully raised €1 million in funding to advance its innovative voice-based solutions for monitoring chronic respiratory diseases, marking a significant milestone in its development.
Tozaro, a biotech company based in Bedfordshire, has successfully secured £6 million in funding from Mercia Asset Management to enhance its gene therapy platform. This investment aims to advance the development of affordable gene therapies and address the pricing crisis in modern medicine.